P
Patrick Vizeli
Researcher at University Hospital of Basel
Publications - 24
Citations - 681
Patrick Vizeli is an academic researcher from University Hospital of Basel. The author has contributed to research in topics: MDMA & Lysergic acid diethylamide. The author has an hindex of 10, co-authored 18 publications receiving 320 citations. Previous affiliations of Patrick Vizeli include University of Basel.
Papers
More filters
Journal ArticleDOI
Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.
Friederike Holze,Patrick Vizeli,Felix Müller,Laura Ley,Raoul Duerig,Nimmy Varghese,Anne Eckert,Stefan Borgwardt,Matthias E. Liechti +8 more
TL;DR: Investigation of the acute autonomic, subjective, and endocrine effects of single doses of LSD, MDMA, and d-amphetamine in 28 healthy subjects indicates clearly distinct acute effects and may assist the dose-finding in substance-assisted psychotherapy research.
Journal ArticleDOI
Safety pharmacology of acute MDMA administration in healthy subjects.
TL;DR: MDMA administration was overall safe in physically and psychiatrically healthy subjects and in a medical setting, however, the risks of MDMA are likely higher in patients with cardiovascular disease and remain to be investigated in Patients with psychiatric disorders.
Journal ArticleDOI
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.
Friederike Holze,Friederike Holze,Patrick Vizeli,Patrick Vizeli,Laura Ley,Laura Ley,Felix Müller,Patrick C. Dolder,Patrick C. Dolder,Melanie Stocker,Melanie Stocker,Urs Duthaler,Urs Duthaler,Nimmy Varghese,Anne Eckert,Stefan Borgwardt,Matthias E. Liechti,Matthias E. Liechti +17 more
TL;DR: The LSD dose–response curve showed a ceiling effect for subjective good effects, and ego dissolution and anxiety increased further at a dose above 100 µg, which may assist with dose finding for future LSD research.
Journal ArticleDOI
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
Friederike Holze,Laura Ley,Felix Müller,Anna Becker,Isabelle Straumann,Patrick Vizeli,Sebastian Silva Kuehne,Marc A. Roder,Urs Duthaler,Karolina E. Kolaczynska,Nimmy Varghese,Anne Eckert,Matthias E. Liechti +12 more
TL;DR: In this paper , a double-blind, randomized, placebo-controlled, crossover design was used in 28 healthy subjects (14 women, 14 men) who underwent five 25-hour sessions and received placebo, LSD (100 and 200 µg), and psilocybin (15 and 30 mg).
Journal ArticleDOI
Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects.
Friederike Holze,Urs Duthaler,Patrick Vizeli,Felix Müller,Stefan Borgwardt,Matthias E. Liechti +5 more
TL;DR: The aim of the present study was to characterize the pharmacokinetics and exposure–subjective response relationship of a novel oral solution of lysergic acid diethylamide (LSD) that was developed for clinical use in research and patients.